Crinetics Pharmaceuticals (CRNX) Stock Chart & Stock Price History $31.53 -1.79 (-5.37%) As of 11:40 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Crinetics Pharmaceuticals (CRNX) Stock Price Performance 5 Day Performance-3.73%1 Month Performance+8.31%3 Month Performance-10.58%Year-To-Date Performance-38.33%1 Year Performance-34.22%5 Year Performance+68.25% CRNX Stock Chart for Tuesday, May, 13, 2025 CRNX Chart by TradingView The Crinetics Pharmaceuticals (CRNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 34.22%, with a year-to-date return of -38.33%. In the past month, the stock has increased 8.31%, reflecting recent market activity. As of the latest close, Crinetics Pharmaceuticals traded at $33.32 with a market cap of $3.12 billion and volume of 1.11 million shares. Five years ago, the stock traded at $18.74, representing a 68.25% increase over that period. At the time, it had a market cap of $628.84 million and a volume of 122,800 shares. Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Crinetics Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/12/2025$30.68$33.32+8.60%$33.58$31.241.11 million shs$3.12 billion05/09/2025$32.75$30.68-6.33%$34.34$30.641.14 million shs$2.87 billion05/08/2025$31.34$32.75+4.51%$33.26$30.671.21 million shs$3.07 billion05/07/2025$30.52$31.34+2.69%$31.65$30.35680,157 shs$2.93 billion05/06/2025$33.65$30.52-9.30%$33.43$30.391.07 million shs$2.86 billion05/05/2025$33.76$33.65-0.33%$34.10$33.35863,412 shs$3.15 billion05/02/2025$33.52$33.76+0.72%$34.68$33.70907,545 shs$3.16 billion05/01/2025$33.39$33.52+0.39%$33.91$32.29652,903 shs$3.14 billion04/30/2025$33.31$33.39+0.24%$33.80$32.84662,955 shs$3.13 billion04/29/2025$33.11$33.31+0.60%$33.59$32.21737,016 shs$3.12 billion Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/28/2025$32.39$33.11+2.22%$33.60$32.43605,996 shs$3.08 billion04/25/2025$33.39$32.39-2.99%$33.02$31.68835,521 shs$3.01 billion04/24/2025$32.37$33.39+3.15%$33.46$31.74981,487 shs$3.11 billion04/23/2025$31.27$32.37+3.52%$32.89$31.821.55 million shs$3.01 billion04/22/2025$30.15$31.27+3.71%$31.30$30.45603,241 shs$2.91 billion04/21/2025$30.42$30.15-0.89%$31.43$29.97669,840 shs$2.81 billion04/18/2025$30.42$30.42$30.58$29.42591,222 shs$2.83 billion04/17/2025$29.58$30.42+2.84%$30.58$29.42591,222 shs$2.83 billion04/16/2025$29.66$29.58-0.27%$29.78$28.75706,748 shs$2.75 billion04/15/2025$29.78$29.66-0.40%$30.46$29.23544,923 shs$2.76 billion04/14/2025$29.11$29.78+2.30%$30.34$28.60911,437 shs$2.77 billion Related Companies Dr. Reddy's Laboratories Stock Chart Moderna Stock Chart Ascendis Pharma A/S Stock Chart Viatris Stock Chart Qiagen Stock Chart Roivant Sciences Stock Chart Revolution Medicines Stock Chart Lantheus Stock Chart BridgeBio Pharma Stock Chart Blueprint Medicines Stock Chart Receive CRNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRNX) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crinetics Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.